Rockwell, B., Goldfinger, M., Mantzaris, I., Shastri, A., Saunthararajah, Y., Gritsman, K., Sica, A. R., Kornblum, N., Shah, N., Levitz, D., Shapiro, L. C., Gupta, R., Munoz, A., Dhawan, A., Fehn, K., Comas, M., Verceles, J., Cooper, D. L., Konopleva, M., Feldman, E. J. and Verma, A. (2020) “Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemia”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2024.287253.